Hilco Vision, a portfolio company of Blue Point Capital Partners, has acquired Eye Care & Cure. This transaction represents the eighth add-on acquisition for Hilco since Blue Point acquired the company in May 2014.
Eye Care & Cure (ECC) is a distributor of a range of optical supplies with more than 4,000 SKUs. The company was founded in 1995 and is headquartered in Tucson, AZ with an additional distribution facility in Chicago (www.eyecareandcure.com).
Hilco Vision is a designer, manufacturer and distributor of eyewear and eye care accessories, supplies and equipment. The company supplies more than 30,000 SKUs to more than 50,000 domestic and international customers. Hilco’s five primary product categories include: professional tools, consumer accessories, lens care, vision protection and eye care supplies. The company, led by CEO Ross Brownlee, is headquartered southwest of Boston in Plainville, MA, with additional operations in Canada, Europe and Australia (www.hilco.com).
“ECC has been a top-priority, strategic acquisition target for Hilco for several years. The company is a strong player in the pharmaceuticals and diagnostics product category and a compelling strategic fit with Hilco’s existing ophthalmic business,” said John LeMay, a partner with Blue Point.
Blue Point is a lower middle market private equity firm that invests in manufacturing, distribution and service businesses that have from $20 million to $300 million in revenue and EBITDA greater than $5 million. The firm has offices in Cleveland, Charlotte, Seattle, and Shanghai (www.bluepointcapital.com).
© 2018 Private Equity Professional | December 6, 2018